ICU Medical
| Company type | Public |
|---|---|
| Industry | Medical technology |
| Founded | 1984 |
| Founder | George "Doc" Lopez, MD |
| Headquarters | San Clemente, California , United States |
Area served | Worldwide |
| Products | Intravenous therapy equipment, infusion pumps, needleless vascular access devices, closed system drug transfer devices, sensor-equipped catheters, closed blood sampling systems, hemodynamic monitoring solutions |
| Website | www |
ICU Medical, Inc. is a company specializing in medical technology, with its headquarters located in San Clemente, California. The firm’s product range is designed to minimize bloodstream infections and safeguard healthcare professionals from exposure to infectious agents and hazardous pharmaceuticals. Its offerings include intravenous (IV) therapy equipment, infusion pumps, needleless vascular access devices, closed system drug transfer devices for handling dangerous drugs, sensor-equipped catheters, closed blood sampling systems, and hemodynamic monitoring solutions.
The company’s solutions for IV medication preparation and administration improve dosing precision and optimize clinical processes. In 2014, ICU Medical earned recognition from Forbes Magazine as one of the 100 Most Trustworthy Companies in the United States.
History
Established in 1984 by physician and entrepreneur George "Doc" Lopez, MD, ICU Medical initially launched the ClickLock device to provide a more secure connection for IV lines. The company entered the oncology sector in 2006 with the introduction of the ChemoClave system, a closed system transfer device (CSTD) designed to allow pharmacists and nurses to handle hazardous chemotherapy drugs safely.
In 2009, ICU Medical expanded its operations by acquiring the Critical Care division formerly owned by Abbott Laboratories from Hospira, following a manufacturing partnership that lasted four years. Further growth occurred in February 2017 when ICU Medical purchased Hospira’s Infusion Systems business from Pfizer. These acquisitions have broadened ICU Medical’s global footprint and enhanced its portfolio in critical care and infusion technology markets.
Products
The Neutron device by ICU Medical addresses catheter occlusion caused by external influences such as connecting or disconnecting luers and variations in patient vascular pressure. Clinical data indicate that Neutron can reduce catheter occlusion rates by approximately 50%.
In 2015, ICU Medical acquired Excelsior Medical Corporation, a company specializing in products for disinfecting and protecting vascular access points. This acquisition included items like SwabCap, SwabFlush, along with pre-filled saline and heparin flush syringes. The transaction was valued at $59.5 million; subsequently, ICU Medical divested the SwabFlush and pre-filled syringe product lines to Medline Industries for $27 million.
Oncology
ICU Medical’s oncology segment concentrates on preventing exposure to hazardous drugs among healthcare workers and patients. In 2012, the company introduced the Diana Hazardous Drug Compounding System—an automated platform that protects clinicians from accidental needlesticks and exposure while ensuring sterile drug compounding.
Critical care
The critical care product portfolio includes real-time hemodynamic monitoring systems, blood conservation technologies, oximetry catheters designed to optimize oxygen delivery and consumption, latex-free critical care catheters, and hemodynamic transducer kits. Their advanced sensor catheters are manufactured without natural rubber latex to reduce allergic reaction risks, thereby improving patient safety.
External links
- Companies listed on the Nasdaq
- 1984 establishments in California
- American companies established in 1984
- Health care companies established in 1984
- Medical technology companies of the United States
- Health care companies based in California
- Companies based in San Clemente, California
- Medical device manufacturers
- Companies of the United States by year of establishment